| Literature DB >> 34070153 |
Gan Huang1, Shu-Ting Pan1, Jia-Xuan Qiu1.
Abstract
Porous tantalum (Ta) is a promising biomaterial and has been applied in orthopedics and dentistry for nearly two decades. The high porosity and interconnected pore structure of porous Ta promise fine bone ingrowth and new bone formation within the inner space, which further guarantee rapid osteointegration and bone-implant stability in the long term. Porous Ta has high wettability and surface energy that can facilitate adherence, proliferation and mineralization of osteoblasts. Meanwhile, the low elastic modulus and high friction coefficient of porous Ta allow it to effectively avoid the stress shield effect, minimize marginal bone loss and ensure primary stability. Accordingly, the satisfactory clinical application of porous Ta-based implants or prostheses is mainly derived from its excellent biological and mechanical properties. With the advent of additive manufacturing, personalized porous Ta-based implants or prostheses have shown their clinical value in the treatment of individual patients who need specially designed implants or prosthesis. In addition, many modification methods have been introduced to enhance the bioactivity and antibacterial property of porous Ta with promising in vitro and in vivo research results. In any case, choosing suitable patients is of great importance to guarantee surgical success after porous Ta insertion.Entities:
Keywords: additive manufacturing; bone tissue engineering; clinical application; porous tantalum; surface modification
Year: 2021 PMID: 34070153 PMCID: PMC8158527 DOI: 10.3390/ma14102647
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1Schematic representation of the relative signaling pathway that may be involved in the osteogenic effect of Ta.
Figure 2The microstructure of porous Ta presented as honeycomb structure (a), and cells that partially cover the cavity with many calcium nodules (indicated with white arrow) can be detected (b). Reprinted from ref. [36]. Abundant bone ingrowth can be found in the pores of porous Ta implant (c). Reprinted with permission from [45]. Copyright © 2021 by American Academy of Orthopaedic Surgeons.
The mechanical properties of osseous tissues and porous Ta produced by different techniques.
| Osseous Tissues | Manufacturing Technique | Porosity (%) | Pore Size (μm) | Strut Size (μm) | Elastic Modulus (GPa) | Compressive Strength (MPa) | Yield Strength (MPa) | 0.2% Proof Strength (MPa) | Ref |
|---|---|---|---|---|---|---|---|---|---|
| Cortical bone | 3–5 | 7–30 | 100–230 | [ | |||||
| Trabecular bone | 50–90 | 0.01–3.0 | 2–12 | ||||||
| CVD | 75–85 | 400–600 | 40–60 | 2.5–3.9 | 42–78 | [ | |||
| CVD | 70–85 | 150–400 | 40–60 | 10–30 | 35–100 | [ | |||
| Foam impregnation | 65–80 | 400–600 | 2.0–4.6 | 100–170 | [ | ||||
| Powder metallurgy | 100–400 | 2.0 ± 0.3 | 50.3 ± 0.5 | [ | |||||
| LENS | 55 | 1.5 ± 0.3 | 100 ± 10 | [ | |||||
| 45 | 7 ± 0.6 | 192 ± 7 | |||||||
| 27 | 20 ± 1.9 | 746 ± 27 | |||||||
| SLM | 80 | 500 | 150 | 1.22 ± 0.07 | 28.3 ± 1.2 | 12.7 ± 0.6 | [ | ||
| SEBM | 75 | 540 | 23.98 ± 1.72 | [ | |||||
| 80 | 392 | 19.48 ± 1.45 | |||||||
| 85 | 386 | 6.78 ± 0.85 | |||||||
| SLM | 70 | 500 | 400 | 3.10 ± 0.03 | [ | ||||
| SLM | 80 | 300–400 | 2.34 ± 0.2 | 78.54 ± 9.1 | [ |
Notes: CVD, Chemical Vapor Deposition; LENS, Laser Engineered Net Shaping; SLM, Selective Laser Melting; SEBM, Selective Electron Beam Melting.
Figure 3Application of porous Ta in different parts of the human body.
Figure 4The typical products of porous Ta-based implants manufactured by Zimmer Biomet Inc. Acetabular cup with porous Ta coating (a). Reprinted with permission from [45]. Copyright © 2021 by American Academy of Orthopaedic Surgeons. Porous Ta lumbar interbody fusion cage (b) Reprinted from ref. [57], porous Ta rod (c) Reprinted from ref. [58] and dental implant (d) Reprinted from ref. [59]. The porous Ta cones were used to reconstruct femoral metaphyseal defect (e–g). Reprinted from ref. [60].
The biological properties of additive manufactured porous Ta scaffolds.
| Porosity%/Samples | In Vitro Tests Results | In Vivo Tests Results | Ref. |
|---|---|---|---|
| 80% Ta | No cytotoxicity | The bone defect can be bridged by the new bone with the help of printed porous Ta scaffold. Rigid bone–implant connection can be obtained. | [ |
| 70% Ta vs. 70% Ti | Cells’ adhesion, proliferation and vitality were similar. ALP and mineralized nodule staining levels were comparable. Sp7 and OCN genes levels were comparable. | Bone ingrowth rate and depth were similar in the two groups. Ti group showed a quick-slow-quick new bone formation pattern. Ta group showed a gradual slowdown style of new bone formation. The two groups had similar push out force. | [ |
| 80% Ta vs. 80% Ti | Ta group showed better cell viability than Ti group. Ta group was higher than Ti group after 5–7 days. Ta group had superior ALP levels and calcium nodule numbers. Levels of Runx2, ALP, Col-1, OCN and OPN genes were higher in Ta group. | Ta could stimulate new bone formation as early as 4 weeks. | [ |
| 30% Ta vs. 30% Ti modified with TiO2 nanotubes, 30% Ti and solid Ti | Not mentioned | Ta group had the most significant bone formation after 12 weeks. Four groups had similar bone–implant interlocking strength. Ta groups had persistent bone ingrown in the pores at 12 weeks. Ti modified with TiO2 nanotubes groups showed comparable seamless bone–implant interface with Ta groups. The other two Ti groups had inferior bone–implant contact. | [ |
| 27% Ta and 45% Ta vs. 27% Ti | Ta groups presented more flattened cell morphologies, filopodia extensions and mineralization than Ti group. Cells proliferated rapidly on Ta samples instead of Ti samples. Porous Ta facilitated cells’ adhesion and differentiation via a porosity-dependent pattern. | Not mentioned | [ |
Note: FESEM, field emission scanning electron microscope; hBMSCs, human bone mesenchymal stem cells.
Figure 5The printed personalized porous Ta knee prosthesis (a), distal femoral component (b) and proximal tibial component (c). The porous Ta prosthesis was inserted into distal femur and proximal tibia, respectively, during the surgery (d,e). Reprinted from ref. [188].
Figure 6The AP (a) and lateral view (b) of X-ray examination at 5-month follow-up showed that the fracture healed after the implantation of the printed porous Ta osteosynthesis plate. Reprinted from ref. [191].
The biological performance of different methods for Ta modification.
| Surface Modification | In Vitro Test Results | In Vivo Test Results | Ref. |
|---|---|---|---|
| ACP nanospheres–PLA coating | Abundant mineral deposition could be formed in 1 week. After being soaked in SBF for 1 day, the hydrophilicity of the two coatings was improved. The two nanostructures possessed satisfactory VEGF-FITC adsorption. The amount of BSA release from ACP nanospheres–PLA coating was faster and larger. The two nano-coatings showed no toxic effects on cells. Cells’ adhesion, interconnecting and spreading were better than those cultured on unmodified samples. |
Significant new bone formation could be found in samples modified by two coatings. By contrast, new bone tissues were lacking in the unmodified samples. | [ |
| CaP nanospheres–PLA coating | CaP nanospheres coating transformed into HA nanosheet which could continuously accumulate on the surface of Ta. CaP nanosheres–PLA coating showed satisfactory hydrophilicity. The transformation from amorphous CaP to HA induced the rapid release of BSA at an early stage. Cells established fine adhesion to CaP nanosheres–PLA coating. |
The modified porous Ta scaffold effectively repaired the defect after 12 weeks. | [ |
| BMP-7 coating | Not mentioned | Modified porous Ta significantly facilitated cartilage restoration at 4, 8 and 16 weeks. Modified porous Ta groups facilitated calcium salt deposition, as well as formation and maturity of bone and cartilage tissues. Sixteen weeks post-surgery, new bone formation could be found around the modified porous Ta. The amount of new bone formation was more than those of unmodified samples. The modified groups possessed higher maximum push out force. | [ |
| Ta2O5 nanotubes films | Ta2O5 nanotube films had excellent biocompatibility and prevented the release of ions. Wettability and surface energy of Ta were enhanced by Ta2O5 nanotube films. Adsorption of BSA and Fn were significantly more on Ta2O5 nanotube films than bare surface, Adhesion and proliferation of rBMSCs were highly enhanced on Ta2O5 nanotube films. Levels of Osterix, ALP, Collagen-I and Osteocalcin were significantly high on the Ta2O5 nanotubes films. Cells cultured on Ta2O5 films presented as polygonal morphology and had more filopodia than those on bare surface. | Not mentioned | [ |
| Nanoporous Ta oxide layers | Nanoporous Ta oxide layers with 25 nm pore size greatly enhanced adhesion, proliferation and extension of fibroblasts. | Not mentioned | [ |
| MAO combined with NaOH treatment | Substantial mineral deposition can be found on the surface of porous Ta treated with MAO and NaOH etching. Cell proliferation on the modified samples was better than the untreated ones at 24, 48 and 72 h. Cells spread over the surface and migrated into the pores of the modified samples, with increasingly filiform protrusions and calcium crystals presented. | New bone formation could be found around the modified samples at 4 weeks. Bone remolding and neovascularization were also found within the pores. The cranial defect could be filled by new bone at 12 weeks. | [ |
| PHAs (PHB, PHBV and PHB4HB)–Genta coating | PHAs coating showed no toxicity to the cells. The concentration of Genta released from PHAs coating effectively inhibited the proliferation of | Not mentioned | [ |
| ZnO nanorods−nanoslices hierarchical structure coating | The novel ZnO coating showed a two-stage release pattern and effective antibacterial properties. The ZnO nanorods–nanoslices coating had no toxic effect on cells. | The ZnO nanorods–nanoslices coating modified Ta foils had ideal antibacterial performance which could last for over 2 weeks in vivo. | [ |
ACP: amorphous calcium phosphate; HA: hydroxyapatite; PLA: polylactic acid; SBF: simulated body fluid; PHAs: polyhydroxyalkanoates; Genta: gentamicin sulfate; BMP-7: bone morphogenetic protein 7; BSA: bovine serum albumin; Fn: fibronectin; rBMSCs: rabbit bone mesenchymal stem cells; BSA: bovine serum albumin; CaP: calcium phosphate; MAO: micro-arc oxidation; E. coli: Escherichia coli; S. aureus: Staphylococcus aureus.
Figure 7Schematic diagram of the surface modification for porous Ta. Amorphous calcium phosphate (ACP) nanospheres and HA nanorods coating on the surface of Ta scaffold (a). Reprinted from ref. [192]. ZnO nanoslices and ZnO nanorods coating on Ta substrate (b), the ZnO nanoslices will be released at an early stage—within 48 h (c), while the ZnO nanorods are released in a slow pattern over 2 weeks (d). Reprinted with permission from [199]. Copyright © 2021 by American Chemical Society.